DMPK CRISPR/Cas9-gene therapy (Genethon)

N/A

Report date: 2025/01/26 19:12:55

Base Information

Drug NameDMPK CRISPR/Cas9-gene therapy (Genethon)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionMyotonin-protein kinase modulators
TargetsMyotonin-protein kinase
Therapy Area/IndicationsMyotonic Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenethon
China Registration ClassN/A

Develop Information

Active CompaniesGenethon
Inactive CompaniesN/A
Active IndicationsMyotonic Dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A